Drinking sugary sodas and sweetened drinks daily is linked to a higher chance of developing rheumatoid arthritis in women over 55, indicating that high sugar intake may play a role in triggering the disease later in life.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A systematic review could quantify the pooled relative risk of EORA associated with sugar-sweetened beverage intake across multiple prospective cohorts.
A systematic review and meta-analysis of prospective cohort studies measuring sugar-sweetened beverage intake (servings/day) in women aged 55+ without RA at baseline, tracking incident seropositive RA over ≥10 years, adjusting for BMI, smoking, and diet quality.
An RCT could determine whether reducing sugar-sweetened beverage intake lowers inflammatory markers in high-risk older women.
A double-blind RCT of 200 women aged 55–75 with high serum anti-CCP titers but no RA, randomized to replace all sugar-sweetened beverages with water or unsweetened tea vs. continued consumption for 18 months, with primary outcome: change in serum IL-6 and anti-CCP titers.
A cohort study could confirm whether sugar intake predicts seroconversion to anti-CCP positivity in older women.
A prospective cohort following 500 women aged 55+ with no RA but elevated anti-CCP, measuring sugar-sweetened beverage intake quarterly and testing anti-CCP and CRP annually for 7 years.
A cross-sectional study could compare sugar intake in women with and without late-onset RA.
A cross-sectional study comparing daily sugar-sweetened beverage intake via food diary in 150 women aged 55+ with seropositive EORA vs. 150 age-matched controls without RA.
A case series could document dietary patterns in women who developed EORA after high sugar intake.
A case series of 15 women aged 55+ newly diagnosed with seropositive EORA, retrospectively documenting sugar-sweetened beverage intake in the 2 years prior to diagnosis.